Correlation Between BioLife Sciences and LeMaitre Vascular

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BioLife Sciences and LeMaitre Vascular at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioLife Sciences and LeMaitre Vascular into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioLife Sciences and LeMaitre Vascular, you can compare the effects of market volatilities on BioLife Sciences and LeMaitre Vascular and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioLife Sciences with a short position of LeMaitre Vascular. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioLife Sciences and LeMaitre Vascular.

Diversification Opportunities for BioLife Sciences and LeMaitre Vascular

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between BioLife and LeMaitre is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding BioLife Sciences and LeMaitre Vascular in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on LeMaitre Vascular and BioLife Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioLife Sciences are associated (or correlated) with LeMaitre Vascular. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of LeMaitre Vascular has no effect on the direction of BioLife Sciences i.e., BioLife Sciences and LeMaitre Vascular go up and down completely randomly.

Pair Corralation between BioLife Sciences and LeMaitre Vascular

Given the investment horizon of 90 days BioLife Sciences is expected to generate 33.08 times more return on investment than LeMaitre Vascular. However, BioLife Sciences is 33.08 times more volatile than LeMaitre Vascular. It trades about 0.11 of its potential returns per unit of risk. LeMaitre Vascular is currently generating about 0.15 per unit of risk. If you would invest  0.01  in BioLife Sciences on September 1, 2024 and sell it today you would earn a total of  0.00  from holding BioLife Sciences or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

BioLife Sciences  vs.  LeMaitre Vascular

 Performance 
       Timeline  
BioLife Sciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BioLife Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, BioLife Sciences is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
LeMaitre Vascular 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in LeMaitre Vascular are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, LeMaitre Vascular unveiled solid returns over the last few months and may actually be approaching a breakup point.

BioLife Sciences and LeMaitre Vascular Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BioLife Sciences and LeMaitre Vascular

The main advantage of trading using opposite BioLife Sciences and LeMaitre Vascular positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioLife Sciences position performs unexpectedly, LeMaitre Vascular can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in LeMaitre Vascular will offset losses from the drop in LeMaitre Vascular's long position.
The idea behind BioLife Sciences and LeMaitre Vascular pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Complementary Tools

Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
CEOs Directory
Screen CEOs from public companies around the world
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.